GlycoMark, Inc., a company based in Manhattan, New York, is dedicated to improving the management and health of patients with diabetes. GlycoMark, Inc. is the exclusive supplier of the GlycoMark test in the United States, Europe, Australia, Indonesia and the Middle East. The GlycoMark test is used around the world to enhance the management of glycemic control in patients with diabetes, which has been diagnosed in nearly 10% of the U.S. population and costs the U.S. healthcare system over $325 billion per year.* The company possesses extensive resources to facilitate the discovery and commercialization of innovative biomarkers and new test methodologies for its product portfolio.
GlycoMark, Inc. is jointly owned by New York Toyota Tsusho America, Inc. (New York, NY), Toyota Tsusho Corporation (Tokyo, Japan), and Nippon Kayaku Co., Ltd. (Tokyo, Japan).
Hirotaka `Hiro` Ishibashi
Hiro has more than 15 years of experience in the biotech industry, specifically with diabetes and its related complications. He has worked in research and analysis of regulatory and industry developments in the U.S. pharmaceutical and biotech market. Hiro has extensive global business development experience in Europe, Asia, the Middle East and Latin America. Hiro holds a Master’s degree in Biotechnology from Columbia University.
Jeff Dahlen, Ph.D.
Vice President of Clinical and Scientific Affairs
Jeff Dahlen, Ph.D., has worked in the in-vitro diagnostics industry for more than 15 years. Prior to joining GlycoMark, he held leadership positions in assay development, clinical affairs, regulatory affairs, medical affairs, and scientific affairs at Biosite, Oculir, and Accumetrics.
Jeff holds a Bachelor of Science degree in Engineering from the University of Illinois and a Ph.D. in Biomedical Sciences (Biochemistry and Molecular Biology) from the University of New Mexico.
Eric Button, M.Sc., MBA
Corporate Advisor and Founder
Eric Button is a medical diagnostics executive who has spent the past 30 years at the forefront of novel diagnostic development and commercialization. Eric has been the founder of several diagnostic companies, including GlycoMark, and led the commercialization of the original PSA prostate cancer test at Hybritech. Eric holds a Master’s degree in Molecular Genetics from the University of British Columbia and an MBA from the University of North Carolina.
Mr. Koie heads up GlycoMark’s corporate strategy and business development, and serves as a member of the board of directors. Prior to GlycoMark, he served as Group Lead of the Life Science Group at Toyota Tsusho Co. (TTC). Prior to TTC, Mr. Koie was responsible for global corporate strategy & planning and business development at Eisai Co. He holds a Master’s degree in Development Studies from University of East Anglia.
Denise Surman, MS, RD, CDE
Senior Sales Specialist/Certified Diabetes Educator
Denise is a Registered Dietitian and Certified Diabetes Educator. Her hands on, clinical expertise includes the management of patients with diabetes, from the newly diagnosed to those with life altering chronic complications, that include chronic kidney disease and obesity. In addition, she has more than 20 years experience in sales and marketing roles within the Pharmaceutical and Biotech industries. Denise completed her clinical training at the University of Medicine and Dentistry of New Jersey, now Rutgers University. She also holds a Master’s of Science degree in Bioinformatics.
Sales Executive Account Manager
Jim is an experienced sales executive with 26 years working in pharmaceutical sales and sales leadership, including selling oral and injectable therapies for managing hyperglycemia. In addition to his background in diabetes management and therapeutics, he has lead training seminars in healthcare management. Jim holds a B.A. in Biology from the New York Institute of Technology, and received a certification in Industry Diabetes Training from the Educational Institute of the American Association of Clinical Endocrinology in 2016.
Marketing and Partner Relations
Lauren brings extensive commercial and clinical diagnostics experience to GlycoMark, with over 20 years of sales, distribution and marketing management experience with Roche Diagnostics, Biosite, Accumetrics and is co-Founder of L3 Healthcare. Lauren focuses on clinical market education and awareness of the GlycoMark Test to help advance the care of patients with diabetes to a broader market segment. She holds a Bachelor’s degree in international business from the University of South Florida.
Kirsten manages the GlycoMark website, conferences and event planning, development of graphics and marketing materials. She possesses over ten years of management and marketing experience and provides world-class support and project management. Kirsten is a graduate of San Diego City College.
*Statistics About Diabetes. http://www.diabetes.org/diabetes-basics/statistics/